Viridium Files Financial Statements
Calgary, Alberta (FSCwire) - Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTC Pink: MRRBF) is pleased to announce that it has filed the unaudited quarterly financial statements and management's discussion and analysis thereon of Experion Biotechnologies Inc. for the period ended August 31, 2017 (the “Financial Statements and MD&A”). As announced on October 2, 2017, Experion Biotechnologies Inc. was a party to the reverse take-over transaction with Morro Bay Resources Ltd. (the “RTO”). As a result of the RTO the Experion Biotechnologies Inc. year end (November 30) has become the year-end of the Corporation. The Financial Statements and MD&A are available for review under the Company's profile on SEDAR at www.sedar.com.
About Viridium
Viridium Pacific Group Ltd. is a consumer wellness and biotech innovation company based in British Columbia, and the parent company of operating subsidiaries involved in horticultural production, property development, and human resource management. Viridium Pacific is the parent company of Experion Biotechnologies Inc., an Health Canada licensed producer of cannabis, which operates in an 8,300 square-foot indoor facility outside of Mission, BC.
More information about Viridium can be found under the Company's profile on SEDAR at www.sedar.com.
Disclosure
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
For further information:
VIRIDIUM PACIFIC GROUP LTD.
Damian Wojcichowsky
VP – Corporate Development
Telephone: +1 (647) 464-3596
Email: damian@viridiumpacific.com
To view this press release as a PDF file, click onto the following link:public://news_release_pdf/Viridium01152018.pdf
Source: Viridium Pacific Group Ltd. (TSX Venture:VIR, OTC Bulletin Board:MRRBD)
To follow Viridium Pacific Group Ltd. on your favorite social media platform or financial websites, please click on the icons below.
Maximum News Dissemination by FSCwire. https://www.fscwire.com
Copyright © 2018 FSCwire